Nutriband Inc (NTRB) Stock Price, Quote & News

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Industry: Biotechnology

Sector: Healthcare

Phone: 407 377 6695

Website: www.nutriband.com

Address:

121 South Orange Avenue, Suite 1500, Orlando, United States

Covode13 Sep. 15 at 6:14 PM

$NTRB back to 4. No reason for this to run up anyways

1 · Reply

bigsnipe Sep. 15 at 3:27 PM

$NTRB bro i should have just bought this when i added it to my watch list rip

1 · Reply

BullInvest Sep. 14 at 3:32 PM

$NTRB here is my prediction. When warrants go voided, we are going to climb back to , when the officialize the comercial name we go to $10. When FDA approves we go to $22. Then from there this stock has potential to climb very high if sales are met.

0 · Reply

birdmanCap Sep. 14 at 2:12 PM

$NTRB she wants $7

0 · Reply

topstockalerts Sep. 11 at 11:16 PM

$NTRB there’s a certain stubbornness to this strength.

0 · Reply

Vondde Sep. 11 at 7:34 PM

$NTRB What's this? Trying to make it harder to use medical-grade fentanyl so even more people will turn to street fentanyl? Sounds like a good time to invest in cartels.

2 · Reply

BullInvest Sep. 11 at 5:22 PM

$NTRB here is what I would love. Healthy uptrend to $10. And then on fda a quick rocket to $25

1 · Reply

longtime Sep. 11 at 3:24 PM

$NTRB

0 · Reply

VictoryWylde Sep. 10 at 6:35 PM

$NTRB @Covode13 are you in a position to sell out at profit yet?

2 · Reply

longtime Sep. 10 at 4:27 PM

$NTRB very low float. a continued pick up in volume will send this skyrocketing. I anticipate seeing a huge move this month. With the news of them having filed a trademark name this week, they are probably extremely close to FFDA approval. This is going to go through the roof.

0 · Reply

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit

NTRBW

2026-09-08T13:26:03.000Z - 7 days ago

Nutriband receives notice of publication from USPTO

Sep 8, 2026, 9:00 AM EDT - 7 days ago

Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch

NTRBW

Aug 13, 2026, 7:00 AM EDT - 4 weeks ago

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

NTRBW

May 15, 2026, 7:00 AM EDT - 4 months ago

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

NTRBW

Apr 22, 2026, 7:00 AM EDT - 4 months ago

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

NTRBW

Mar 30, 2026, 4:05 PM EDT - 5 months ago

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

NTRBW

2026-03-18T11:16:16.000Z - 6 months ago

Nutriband’s Kinesiology Tapes approved for distribution and sale in Costa Rica

Feb 17, 2026, 7:28 AM EST - 7 months ago

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

NTRBW

2026-02-17T12:17:11.000Z - 7 months ago

Nutriband signs exclusive distribution agreement with Innomedica

2026-01-30T12:20:44.000Z - 7 months ago

Nutriband provides summary of annual shareholder meeting

Jan 30, 2026, 7:00 AM EST - 7 months ago

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

NTRBW

2025-12-31T12:10:36.000Z - 8 months ago

Nutriband says ‘committed’ to shareholder value as ‘number one focus’

Dec 31, 2025, 7:00 AM EST - 8 months ago

Nutriband CEO Publishes Letter to Shareholders

NTRBW

2025-12-29T14:05:16.000Z - 8 months ago

Nutriband to sell majority stake of Pocono Pharmaceutical for $5M

Dec 29, 2025, 9:00 AM EST - 8 months ago

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

NTRBW

2025-12-18T13:05:49.000Z - 9 months ago

Nutriband signs LOI with Qvanta Group of companies

2025-12-18T12:10:38.000Z - 9 months ago

Nutriband provides response to Trump’s Executive Order related to fentanyl

Dec 18, 2025, 7:00 AM EST - 9 months ago

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

NTRBW

Nov 24, 2025, 7:00 AM EST - 9 months ago

Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference

NTRBW

Oct 28, 2025, 11:05 AM EDT - 10 months ago

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

NTRBW

2025-10-28T11:15:36.000Z - 10 months ago

Nutriband announces meeting completed with U.S. FDA for AVERSA FENTANYL

Oct 28, 2025, 7:00 AM EDT - 10 months ago

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

NTRBW

2025-10-27T11:11:14.000Z - 10 months ago

Nutriband co-founder Gareth Sheridan returns as CEO

2025-10-10T11:05:38.000Z - 11 months ago

Nutriband signs agreement with Brand Institute to develop brand for patch

Oct 10, 2025, 7:00 AM EDT - 11 months ago

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

NTRBW

2025-10-08T12:41:02.000Z - 11 months ago

Nutriband files provisional patent application for AVERSA technology

Oct 8, 2025, 8:30 AM EDT - 11 months ago

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

NTRBW

Oct 8, 2025, 6:30 AM EDT - 11 months ago

Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference

NTRBW

Sep 24, 2025, 4:05 PM EDT - 11 months ago

Nutriband Inc. to Present at the MicroCap Rodeo Conference

NTRBW

2025-09-10T13:20:17.000Z - 1 year ago

Nutriband reports Q2 EPS ($2.12) vs. (15c) last year

Sep 10, 2025, 9:15 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

NTRBW

Sep 3, 2025, 4:01 PM EDT - 1 year ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

NTRBW

Aug 18, 2025, 9:00 AM EDT - 1 year ago

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

2025-08-11T09:10:24.000Z - 1 year ago

Nutriband CEO Gareth Sheridan steps aside for Irish election

Aug 11, 2025, 5:00 AM EDT - 1 year ago

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

NTRBW

2025-08-08T12:11:35.000Z - 1 year ago

Nutriband announces FDA granted Type C Meeting for AVERSA FENTANYL

Aug 8, 2025, 8:00 AM EDT - 1 year ago

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

2025-07-18T13:20:11.000Z - 1 year ago

Nutriband confirms record, pay date for 25% preferred stock dividend

Jul 18, 2025, 9:15 AM EDT - 1 year ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

NTRBW

2025-07-02T12:21:15.000Z - 1 year ago

Nutriband board approves 25% Preferred Stock dividend

Jul 2, 2025, 8:05 AM EDT - 1 year ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

NTRBW

2025-07-01T11:15:18.000Z - 1 year ago

Nutriband added to Russell Microcap, Russell Microcap Growth, Russell 3000E

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

NTRBW

Jun 9, 2025, 7:30 AM EDT - 1 year ago

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

NTRBW

Apr 11, 2025, 7:00 AM EDT - 1 year ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

NTRBW

Apr 4, 2025, 5:41 PM EDT - 1 year ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

NTRBW

Apr 4, 2025, 7:00 AM EDT - 1 year ago

Nutriband Signs Partnership Agreement with Charlotte FC

NTRBW

Feb 21, 2025, 7:00 AM EST - 1 year ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

NTRBW

Feb 13, 2025, 7:00 AM EST - 1 year ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Feb 7, 2025, 8:45 AM EST - 1 year ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

NTRBW

Dec 31, 2024, 7:00 AM EST - 1 year ago

Nutriband Issues Letter to Shareholders

NTRBW

Dec 27, 2024, 9:25 AM EST - 1 year ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

NTRBW

Dec 4, 2024, 9:00 AM EST - 1 year ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Nov 27, 2024, 7:00 AM EST - 1 year ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

NTRBW

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

NTRBW

Oct 17, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

NTRBW

Oct 2, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

NTRBW

Sep 24, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

NTRBW

Sep 20, 2024, 6:50 AM EDT - 1 year ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

NTRBW

Sep 16, 2024, 4:00 PM EDT - 1 year ago

Nutriband Inc. Authorizes $1M Share Buyback Program

NTRBW

Sep 4, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Jul 19, 2024, 7:00 AM EDT - 2 years ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

NTRBW

Jul 15, 2024, 7:00 AM EDT - 2 years ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

NTRBW

Jun 20, 2024, 7:00 AM EDT - 2 years ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

NTRBW

Jun 3, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

NTRBW

May 16, 2024, 7:00 AM EDT - 2 years ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

NTRBW

May 10, 2024, 9:00 AM EDT - 2 years ago

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

CANF

Covode13 Sep. 15 at 6:14 PM

$NTRB back to 4. No reason for this to run up anyways

1 · Reply

bigsnipe Sep. 15 at 3:27 PM

$NTRB bro i should have just bought this when i added it to my watch list rip

1 · Reply

BullInvest Sep. 14 at 3:32 PM

0 · Reply

birdmanCap Sep. 14 at 2:12 PM

$NTRB she wants $7

0 · Reply

topstockalerts Sep. 11 at 11:16 PM

$NTRB there’s a certain stubbornness to this strength.

0 · Reply

Vondde Sep. 11 at 7:34 PM

$NTRB What's this? Trying to make it harder to use medical-grade fentanyl so even more people will turn to street fentanyl? Sounds like a good time to invest in cartels.

2 · Reply

BullInvest Sep. 11 at 5:22 PM

$NTRB here is what I would love. Healthy uptrend to $10. And then on fda a quick rocket to $25

1 · Reply

longtime Sep. 11 at 3:24 PM

$NTRB

0 · Reply

VictoryWylde Sep. 10 at 6:35 PM

$NTRB @Covode13 are you in a position to sell out at profit yet?

2 · Reply

longtime Sep. 10 at 4:27 PM

0 · Reply

NNTrader Sep. 10 at 5:59 AM

$NTRB bullish

0 · Reply

birdmanCap Sep. 9 at 6:39 PM

$NTRB she wants 6 + I can feel it in my bones!

0 · Reply

nutriband_com Sep. 9 at 4:28 PM

$NTRB Nutriband CEO Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on Sept. 16 at Nasdaq MarketSite in New York. The Summit brings together biotech executives, investors and industry leaders for thought leadership and networking. 🔗 Full release: https://www.nutriband.com/post/nutriband-ceo-gareth-sheridan-to-attend-the-nasdaq-life-sciences-advisory-board-lab-biotech-summi #NTRB #Nutriband #Nasdaq #Biotech #LifeSciences

0 · Reply

nutriband_com Sep. 9 at 9:22 AM

$NTRB Nutriband received a USPTO Notice of Publication for commercial brand name trademarks associated with its lead abuse-deterrent fentanyl transdermal system. If no objections are filed during the 30-day opposition period, the USPTO is expected to issue a Notice of Allowance. The product is based on Nutriband’s proprietary AVERSA™ abuse-deterrent technology. 🔗 Full release: https://www.nutriband.com/post/nutriband-receives-uspto-notice-of-publication-of-commercial-brand-name-trademarks-for-its-abuse-det #NTRB #Nutriband #AVERSA #Biotech #DrugDevelopment

0 · Reply

Market Cap	84.61M
Revenue (ttm)	2.04M
Net Income (ttm)	-8.23M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-403.43%
Debt to Equity Ratio	0.01

Volume	45,500
Avg Vol	31,364
Day's Range	N/A - N/A
Shares Out	12.16M
Stochastic %K	96%
Beta	2.03
Analysts	Strong Sell
Price Target	$15.00